AVITA Medical (AVHHL) Short-term Investments (2021 - 2025)

AVITA Medical has reported Short-term Investments for 5 years, with the latest figure at $7.9 million in Q4 2025.

• For the quarter ending Q4 2025, Short-term Investments fell 63.63% year-over-year to $7.9 million; the trailing twelve-month figure through Dec 2025 stood at $7.9 million (down 63.63% YoY), and the FY2025 full-year result was $7.9 million, down 63.63% from the prior year.
• Short-term Investments for Q4 2025 stood at $7.9 million, up from $7.9 million in the prior quarter.
• The five-year high for Short-term Investments was $66.9 million in Q4 2023, with the low at $3.5 million in Q2 2025.
• Historically, Short-term Investments has averaged $33.7 million across 5 years, with a median of $29.7 million in 2021.
• Annual changes were most pronounced in 2024 — Short-term Investments surged 178.13% — and 2025, when it sank 90.51%.
• AVITA Medical's Short-term Investments stood at $29.6 million in 2021, then soared by 106.34% to $61.2 million in 2022, then gained by 9.42% to $66.9 million in 2023, then plunged by 67.38% to $21.8 million in 2024, then tumbled by 63.63% to $7.9 million in 2025.
• The last three Short-term Investments figures came in at $7.9 million (Q4 2025), $7.9 million (Q3 2025), and $3.5 million (Q2 2025), per Business Quant data.